Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Controlled Trial of Citalopram Added to Methylphenidate in Youth With Severe Mood Dysregulation

NCT00794040 is registered in ClinicalTrials.gov with National Institute of Mental Health (NIMH) as lead sponsor.

NCT NCT00794040
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00794040 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Controlled Trial of Citalopram Added to Methylphenidate in Youth With Severe Mood Dysregulation
Lead sponsor
National Institute of Mental Health (NIMH)
Phase
Phase 2
Overall status
Completed
Start date
November 17, 2008
Completion date
February 1, 2018
Enrollment
103 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

attention deficit and disruptive behavior disorder, attention deficit hyperactivity disorder, mental disorder diagnosed in childhood, mood disorder